New products, including long-acting formulations, will be critical to achieve HIV treatment and prevention targets and close gaps among populations with unmet need. In June 2022, at a community forum on CAB-LA access, CHAI facilitated an interactive exercise to engage participants with real-time decision-making on pipeline products, facilitate discussion around choice, and distill insights related to product development, counseling, and demand generation. This brief summarizes the findings of that activity.
Comments